Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Andrew C. Elden(University of Pennsylvania), Hyung Jun Kim(Howard Hughes Medical Institute), Michael P. Hart(University of Pennsylvania), Alice Chen‐Plotkin(University of Pennsylvania), Brian S. Johnson(University of Pennsylvania), Xiaodong Fang(University of Pennsylvania), Maria Armakola(University of Pennsylvania), Felix Geser(University of Pennsylvania), Robert A. Greene(University of Pennsylvania), Min Lü(University of Pennsylvania), Arun Padmanabhan(University of Pennsylvania), Dana Clay-Falcone(University of Pennsylvania), Leo McCluskey(University of Pennsylvania), Lauren Elman(University of Pennsylvania), Denise Juhr(Children's Hospital of Philadelphia), Peter J. Gruber(Children's Hospital of Philadelphia), Udo Rüb(Goethe University Frankfurt), Georg Auburger(Goethe University Frankfurt), John Q. Trojanowski(University of Pennsylvania), Virginia M.‐Y. Lee(University of Pennsylvania), Vivianna M. Van Deerlin(University of Pennsylvania), Nancy M. Bonini(Howard Hughes Medical Institute), Aaron D. Gitler(University of Pennsylvania)
Cited by 1,336